Skip to main content

Table 3 The incidence of β-human chorionic gonadotropin (β-hCG) expression. The incidence of β-hCG expression was determined by the presence of β-hCG immunolocalization in groups of EGFP-fusion protein expressing cells. Data are from three independent experiments.

From: Integrin-linked kinase can facilitate syncytialization and hormonal differentiation of the human trophoblast-derived BeWo cell line

Experiment

BeWo + pEGFP-C3

BeWo + pEGFP-C3- dn-ILK

BeWo + pEGFP-C3- wt-ILK

BeWo + pEGFP-C3- ca-ILK

1

16/40

13/68

27/47

46/57

2

23/57

8/51

30/47

49/61

3

20/43

15/55

22/36

38/55

Avg. Incidence (% of 1.00 +/- SEM)

0.43 +/- 0.02

a0.22 +/- 0.03

b0.62 +/- 0.02

b, c0.77 +/- 0.04

  1. a: Cytoplasmic β-hCG expression markedly decreased in cells expressing dominant negative (dn)-ILK relative to pEGFP-C3 (empty vector) cells (p < 0.05)
  2. b: Expression was significantly increased in cells expressing wildtype (wt)- and constitutively active (ca)-ILK compared to cells expressing empty vector or dn-ILK (p < 0.05)
  3. c: Cytoplasmic β-hCG expression was significantly increased in cells expressing ca-ILK compared to cells expressing wt-ILK (p < 0.05)